Although host responses to the ancestral SARS-CoV-2 strain are well described, those to
the new Omicron variants are less resolved. We profiled the clinical phenomes …

Increasing proteomic studies focused on epithelial ovarian cancer (EOC) have attempted to
identify early disease biomarkers, establish molecular stratification, and discover novel …

The ancestral SARS-CoV-2 strain that initiated the Covid-19 pandemic at the end of 2019
has rapidly mutated into multiple variants of concern with variable pathogenicity and …

Among the numerous variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) that have been reported worldwide, the emergence of the Omicron variant has …

Since its outbreak in late 2021, the Omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) has been widely reported to be able to evade neutralizing …

DNAX activating protein of 12 kDa (DAP12)-deficiency mice showed impaired differentiation
of oligodendrocytes and reduced myelin in the central nervous system. Whether DAP12 is …

The understanding of dynamic plasma proteome features in hybrid immunity and
breakthrough infection is limited. A deeper understanding of the immune differences …

Background Presently, the omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) dominates amid the coronavirus disease 2019 (COVID-19) …

The persistence of coronavirus disease 2019 (COVID-19)-related hospitalization severely
threatens medical systems worldwide and has increased the need for reliable detection of …

SARS-CoV-2 continues to threaten human society by generating novel variants via mutation
and recombination. The high number of mutations that appeared in emerging variants not …